NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID-19
- Respiratory Failure
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure. Propose adaptations to HACOR score based on the "state of art" of COVID-19 - this adaptations may include radiologic aggravation and monitoring of CRF, ferritin, ...
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure. Propose adaptations to HACOR score based on the "state of art" of COVID-19 - this adaptations may include radiologic aggravation and monitoring of CRF, ferritin, LDH, d-dimers, NT-proBNP, troponin I, GOT, GPT, blood count
Tracking Information
- NCT #
- NCT04342104
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Miguel Guia Hospital General Universitario Morales Meseguer Study Director: Antonio Esquinas Hospital General Universitario Morales Meseguer
Get Well Soon